Blog Tool

Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate...

Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate...

NIH STTR Fast-Track grant helps propel Sensydia's non-invasive CPS platform building on recent funding round Los Angeles, CA – June 5,...

Sensydia continues to push the boundaries of AI in heart function assessment Los Angeles, CA – May 9, 2023 – Non-invasive cardiac...

Completion of enrollment for this 225-subject study is a key milestone on the path to delivering the first device for non-invasive and...

External device uses heart sound and AI to deliver rapid cardiac function assessments via tablet to expand hemodynamic evaluation beyond...

Los Angeles – October 1, 2019 – Sensydia Corporation, an innovator in rapid, non-invasive measurement of critical cardiac function,...

The Sensydia Cardiac Performance System (CPS) is the first patient-worn system to provide Ejection Fraction information to clinicians for...

Sensydia Corporation announces that it has complete a Series B financing. The financing was led by Colle Capital and included all Series...

Sensydia Corporation has completed its first round of financing which will be used to develop its patent pending technology to detect...